Updated Brand Names Guide

Get your updated Brand Names Guide that has the following added brand name studies:

• PAUSE (ITN059AI)
  Efficacy of Ustekinumab followed by Abatacept for the Treatment of Psoriasis Vulgaris
• EXTEND (ITN058AI)
  Preserving Beta-Cell Function with Tocilizumab in New-onset Type 1 Diabetes

As always, you can find this guide on the Member Portal within the Shortcuts list.